Daniel Suhr

With a career dedicated exclusively to the pharmaceutical industry, I have acquired extensive expertise and knowledge in pharmaceutical pricing overall, with a specific focus on optimizing launch sequences and international reference pricing.

In my role as the CEO of Two Scenarios, my specialization lies in fine-tuning prices for pharmaceutical companies, especially in the context of international reference pricing. We are committed to assisting our clients in optimizing their pricing processes, helping them save significant costs through our in-depth technical understanding of international reference pricing mechanisms.

At Two Scenarios, agility is paramount. We excel in rapidly developing and implementing solutions for our clients, ensuring that no time is wasted in achieving their goals.